Table III.
Characteristics and outcome of our case series
| No. of cases | Age [year] | Sex | Ascites | Pleural effusion | Previous thoracocentesis | Sclerosing agent | No. of sessions | Length of stay | Complications | Follow-up/3 months |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 50 | F | Moderate | Rt Massive | 2 | Bovoiodine | 1 | 7 | _ | No recurrence |
| 2 | 53 | M | Mild | Rt Massive | 3 | Bovoiodine | 2 | 14 | Wound infection | Recurrence with encysted effusion |
| 3 | 62 | F | Moderate | Rt Moderate | 4 | Vibramycin | 2 | 12 | _ | No recurrence |
| 4 | 70 | M | Mild | Rt Massive | 3 | Vibramycin | 1 | 4 | _ | No recurrence |
| 5 | 51 | F | Moderate | Rt Moderate | 3 | Talc | 2 | 11 | _ | No recurrence |
| 6 | 63 | M | Moderate | Rt Massive | 3 | Talc | 3 | 15 | Pain | Recurrence of minimal effusion |
| 7 | 68 | M | Mild | Rt Massive | 4 | Vibramycin | 2 | 13 | Hepatic precoma (4 days after thoracoscopy) | No recurrence |
| 8 | 65 | M | Moderate | Rt Massive | 3 | Vibramycin | 2 | 9 | Minimal left pleural effusion | Recurrence of minimal effusion |
| 9 | 57 | M | Mild | Rt Massive | 5 | Talc | 3 | 16 | Patient had rapid increase of bilirubin and creatinine and patient had hepatic coma and died 14 days after thoracoscopy | |
| 10 | 50 | M | Mild | Rt Massive | 4 | Bovoiodine | 2 | 11 | _ | No recurrence |
| 11 | 52 | M | Mild | Rt Moderate | 3 | Bovoiodine | 2 | 11 | Failure of the lung to expand and lung expanded by –ve suction | No recurrence |
| 12 | 43 | M | Moderate | Rt Massive | 5 | Talc | 1 | 7 | _ | Follow-up of patient failed |
| 13 | 56 | M | Moderate | Rt Massive | 3 | Bovoiodine | 2 | 10 | Wound infection | No recurrence |
| 14 | 51 | M | Moderate | Rt Massive | 3 | Bovoiodine | 2 | 8 | *Surgical emphysema *Tense ascites 2 months after procedure (tapping of 3 l) | No recurrence |
| 15 | 68 | M | – | Rt Massive | 4 | Bovoiodine | 2 | 10 | _ | No recurrence |
| 16 | 45 | M | Moderate | Rt Massive | 3 | Vibramycin | 2 | 13 | *Surgical emphysema *Minimal left pleural effusion | Follow-up of patient failed |
| 17 | 50 | F | Moderate | Rt Massive | 3 | Vibramycin | 2 | 8 | _ | No recurrence |
| 18 | 54 | M | Moderate | Rt Moderate | 3 | Talc | 2 | 14 | Surgical emphysema | No recurrence |
| 19 | 45 | M | Moderate | Rt Massive | 4 | Talc | 3 | 15 | _ | No recurrence |
| 20 | 52 | M | Moderate | Rt Moderate | 3 | Bovoiodine | 2 | 9 | Surgical emphysema | No recurrence |
| 21 | 53 | M | Moderate | Rt Massive | 3 | Bovoiodine | 2 | 11 | _ | Follow-up of patient failed |
| 22 | 42 | M | Moderate | Rt Massive | 3 | Vibramycin | 3 | 18 | *Tense ascites *Hepatic coma 3 months later | Recurrence with encysted effusion |
| 23 | 48 | M | Mild | Rt Moderate | 4 | Talc | 2 | 8 | Left minimal pleural effusion disappeared after tube removal | No recurrence |